563 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Yahalom
    Yahalom
  4. Noy
    Noy
  5. De Angelis
    De Angelis
  6. Perales
    Perales
  7. Abrey
    Abrey
  8. Palomba
    Palomba
  9. Younes
    Younes
  10. Matasar
    Matasar

Groups

  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)
  7. Bone Marrow Transplant (65)
  8. GSK Faculty (60)
  9. Epidemiology and Biostatistics (58)
  10. Adult Leukemia (53)
  1. "rituximab"
Formats
  1. Journal Article (489)
  2. Review (36)
  3. Research Letter (13)
  4. Editorial (9)
  5. Correspondence (6)
  6. Meeting Abstract (4)
  7. Book Section (2)
  8. Conference Paper (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)

More Groups

People
  1. Andrew Zelenetz (87)
  2. Craig Moskowitz (52)
  3. Joachim Yahalom (39)
  4. Ariela Noy (35)
  5. Lisa De Angelis (32)
  6. Paul Hamlin (32)

More People

Years
  1. 2025 (21)
  2. 2024 (36)
  3. 2023 (36)
  4. 2022 (28)
  5. 2021 (14)
  6. 2020 (25)

More Years

Publications
  1. Blood (43)
  2. Leukemia and Lymphoma (38)
  3. Journal of Clinical Oncology (32)
  4. Haematologica (21)
  5. British Journal of Haematology (20)
  6. Journal of the National Comprehensive Cancer Network (16)

More Publications

Publishers
  1. Elsevier Inc. (70)
  2. American Society of Hematology (61)
  3. Taylor & Francis Group (44)
  4. Springer (42)
  5. American Society of Clinical Oncology (36)
  6. Nature Publishing Group (28)

More Publishers

Results (563)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: A multicenter observational study
    Journal Article

    Khan, N.; Lindner, S.; Gomes, A. L. C.; Devlin, S. M.; Shah, G. L.; Sung, A. D.; Sauter, C. S.; Landau, H. J.; Dahi, P. B.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
    Review

    Lumish, M.; Falchi, L.; Imber, B. S.; Scordo, M.; von Keudell, G.; Joffe, E.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Treatment of diffuse alveolar hemorrhage: Controlling inflammation and obtaining rapid and effective hemostasis
    Review

    Park, J. A.
    International Journal of Molecular Sciences (2021)

    Fulltext@MSK | Save
  • Infectious disease complications in patients with cancer
    Review

    Seo, S. K.; Liu, C.; Dadwal, S. S.
    Critical Care Clinics (2021)

    Fulltext@MSK | Save
  • Hairy cell leukemia
    Book Section

    Geyer, M. B.; Abdel-Wahab, O.; Tallman, M. S.; Park, J. H.
    In Niederhuber, J. E.; Armitage, J. O.; Kastan, M. B.; Doroshow, J. H.; Tepper, J. E. (Eds.) Abeloff’s Clinical Oncology. 6th ed (2020)

    Fulltext@MSK | Save
  • Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: Long-term follow-up and biomarker analysis
    Journal Article

    Noy, A.; de Vos, S.; Coleman, M.; Martin, P.; Flowers, C. R.; Thieblemont, C.; Morschhauser, F.; Collins, G. P.; Ma, S.; Peles, S.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study
    Journal Article

    Cuneo, A.; Mato, A. R.; Rigolin, G. M.; Piciocchi, A.; Gentile, M.; Laurenti, L.; Allan, J. N.; Pagel, J. M.; Brander, D. M.; Hill, B. T.; more...
    Cancer Medicine (2020)

    Fulltext@MSK | Save
  • Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy
    Editorial

    Mondello, P.; Zelenetz, A. D.
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save